English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: CMV infection constitutes a real risk of pathogenecity in immunocompromised patient. HIV- infected patients who require transfusion are at high risk of developing symptomatic CMV infection when they are transfused with CMV-infected donor blood. This study intends to determine CMV infection risk in correlation with blood transfusion in a population of HIV- infected patients Methods: The study was carried out amongst clients attending HIV clinic at Lagos University Teaching Hospital (LUTH), who were recruited consecutively. Replacement blood donors of the hospital were recruited as controls. A total of 10mls of blood sample was collected per consenting participant. The serum obtained from 5ml of blood was assayed for CMV IgG/IgM using an enzyme- linked immunosorbent assay (ELISA) based Kit whilst full blood count and CD4 cell counts were also performed on the remaining 5mls. Results: A total of 129 HIV-infected were studied. All (100%) were IgG anti-CMV positive. 8 (6.6%) were IgM anti- CMV positive. This difference was found to be statistically significant P=0.004, (P<0.05). Of 122 replacement blood donor controls, 118 (96%) of them were IgG anti-CMV positive whilst 26 (19.5%) of 121 were IgM anti-CMV positive.The mean CD4+ cell count of HIV-infected patients was (234 ± 173.181). Previous history of blood transfusion did not affect CMV antibody positivity directly. Conclusion: The seroprevalence of CMV is very high in HIV-infected patients, which is comparable to the seroprevalence amongst the general population The use of leukoreduced blood units for anaemic HIV infected patients, is recommended. Keywords: Seroprevalence; CMV IgG/IgM; ELISA; healthy blood donors; HIV-infected patients. DOI: 10.3329/jom.v11i2.5462 J MEDICINE 2010; 11 : 151-154

Cytomegalovirus Antibodies Amongst Immunocompromised (HIV) Patients At Lagos University Teaching Hospital (LUTH) Idi - Araba, Lagos